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Abstract: Vaccination uptake has decreased globally in recent years, with a subsequent rise of
vaccine-preventable diseases. Travellers, immunocompromised patients (ICP), and healthcare
workers (HCW) are groups at increased risk for (severe) infectious diseases due to their behaviour,
health, or occupation, respectively. While targeted vaccination guidelines are available, vaccination
uptake seems low. In this review, we give a comprehensive overview of determinants—based
on the integrated change model—predicting vaccination uptake in these groups. In travellers,
low perceived risk of infection and low awareness of vaccination recommendations contributed to
low uptake. Additionally, ICP were often unaware of the recommended vaccinations. A physician’s
recommendation is strongly correlated with higher uptake. Furthermore, ICP appeared to be
mainly concerned about the risks of vaccination and fear of deterioration of their underlying disease.
For HCW, perceived risk of (the severity of) infection for themselves and for their patients together with
perceived benefits of vaccination contribute most to their vaccination behaviour. As the determinants
that affect uptake are numerous and diverse, we argue that future studies and interventions should
be based on multifactorial health behaviour models, especially for travellers and ICP as only a limited
number of such studies is available yet.
Keywords: vaccination uptake; vaccine refusal; vaccine hesitancy; risk groups; immunocompromised;
travellers; healthcare workers; health behaviour model; determinants
1. Introduction
Vaccinations have proven to play a major role in the prevention and control of many infectious
diseases. However, in the twenty-first century, vaccination programs face multiple challenges [1].
The first one is the need for fast development of effective and safe vaccines for new (re-)emerging
pathogens. The recent SARS-CoV-2 pandemic is an example in which a vaccination is highly desired
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and may reduce the enormous impact of the current pandemic. The second challenge in the field of
vaccinology is the upcoming trend of vaccine hesitancy and declining vaccination uptake.
Vaccine hesitancy is recognised by the World Health Organization (WHO) to be one of the ten
threats to global health [2]. Vaccination uptake is declining globally, resulting in a rise in outbreaks of
vaccine-preventable diseases (VPD) [3]. For instance, measles cases have increased—up to 300 percent—
over the past years [4]. Vaccine hesitancy has predominantly received attention in the light of parents
rejecting the national immunization programs. However, low vaccination uptake among adult
populations also raises concerns [5]. Adults are progressively at risk for infectious diseases because life
expectancy increases [6], the incidence of chronic diseases that require immunosuppressive treatment
rises [7], and international travel expands [8]. Other determinants will play a role in vaccination uptake
in adult populations as compared to children.
Adults who are recommended to get vaccinated can be divided into several risk groups.
Risk populations in this context are defined as groups of human individuals with an increased
risk of acquiring a (severe) infection due to their behaviour, health, or occupation. To get a broad
overview of determinants that play a role in the vaccination uptake among risk groups, this review will
focus on three distinct risk groups which consult vaccination clinics frequently, namely: “travellers,
immunocompromised patients (ICP) and healthcare workers (HCW)”.
Travellers comprise a risk population, as at their destinations they can be exposed to infectious
diseases they have not encountered before. Traveller vaccination guidelines are available to protect
this population. These guidelines do not only differ per destination but are also dependent on the
activities the travellers will undertake and the duration of their stay. Additionally, the country of
origin is of importance, because of the endemicity of infectious diseases and therefore natural exposure,
and national immunization programs. Moreover, travellers who are not properly vaccinated for their
trip are not only at risk for getting sick themselves, they can also create a public health concern for
communicable diseases, as they could carry an infection back home to a naïve population [9].
ICP have an increased risk for serious illnesses caused by infectious diseases due to a diminished
function of their immune system. The compromised state of their immune system can be induced
by either an underlying disease or the treatment of a disease. As a consequence of fast-developing
immunosuppressive therapies for e.g., auto-immune diseases and malignancies, ICP are a constantly
growing population [7]. Therefore, optimal protection of this vulnerable group is of utmost importance.
HCW are another risk category for acquiring infectious diseases. Their occupation brings them
in close contact with patients, that possibly carry an infectious disease. Furthermore, HCW are
not only personally at risk, they may also put their—mostly vulnerable—patients at risk when
they work while carrying an infection [10]. On top of that, HCW play an important role in
providing their (immunocompromised or travelling) patients with information or recommendations
regarding vaccinations.
Vaccination uptake varies between risk populations and there may be differences in determinants
that play a role in this behaviour. To find general patterns each risk group will be studied separately.
However, as travellers, ICP, and HCW are interrelated, we aim to learn from similarities and differences
between these groups. If we understand risk populations’ motivations and concerns, we might be able
to address these either separately or combined by effective interventions. To get a better overview
of all determinants that have a possible impact on uptake, we classified these in a model of health
behaviour change.
An abundance of behaviour change models are available that describe determinants affecting
preventive health behaviour [11]. In 2003, the integrated change (I-Change) model was developed
by de Vries et al. [12]. This model is derived from the attitude-social norm-self-efficacy (ASE) model
and integrates several other models, among which are the often-used health belief model (HBM)
and the theory of planned behaviour (TPB) (Supplementary Table S1). According to the I-Change
model, vaccination behaviour is shaped by the intention to get vaccinated which is subject to barriers
and facilitators. Intention is established by motivation, awareness, information, and predisposing
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determinants. As this I-Change model comprises a wide variety of determinants that are used
by other studies, for example those based on the HBM and ASE model, we use this model as a
conceptual framework.
With this comprehensive review, we aim to better understand determinants that play a role in
the uptake of vaccinations in travellers, ICP, and HCW and explore similarities and differences in
these three groups. Hereby, we aim to create a solid ground for the development of evidence-based
interventions to increase vaccination uptake in the populations that need optimal prevention strategies
for infectious diseases.
2. Methods
2.1. Search Strategy
We performed a systematic database search on 19 February 2020. We performed one search for
all three risk groups (Supplementary File S1). For each risk groups we combined search terms for
vaccination uptake and health behavioural models. We searched the following databases: Embase,
Medline, Cinahl, Web of Science Core Collection, ERIC, PsychINFO, and SocINDEX. As determinants
of vaccination uptake may vary over time, we limited our search to studies published during the
last ten years (between 1 January 2010 and 1 January 2020). We excluded research papers written in
another language than English. All records were retrieved into an EndNote database. Duplicates were
removed and titles and abstracts were screened (by LD). Thereafter, papers were sorted in the three
different groups and full texts articles were reviewed for suitability using inclusion and exclusion
criteria (by L.D. and L.v.L.) using EndNote X9.
2.2. Study Selection
Studies were included if they met all of the following criteria: (1) at least 75% of the included
respondents are either ICP (patients with autoimmune diseases, malignancies, HIV, asplenia and solid
organ or stem cell transplantations) or travellers (including travellers visiting friends and relatives
(VFR), short- and long-term business travellers) or HCW (including general practitioners (GPs),
physicians and nurses working in a hospital); (2) addressing self-reported cognitive determinants that
may explain vaccination uptake; and (3) being performed in Western countries (defined as Europe,
North America, Australia, and New Zealand).
We excluded studies that focussed on: (1) children; (2) HCW who care for populations other
than the ICP defined in our study (e.g., paediatricians, elderly home physicians) or who are not
directly involved in the care for this group (e.g., pharmacists, dentists); (3) future healthcare workers
(e.g., medicine or nursing students); (4) uptake of the national immunization programme (e.g., HPV
vaccination); (5) hypothetical vaccinations (e.g., a HIV vaccine); (6) vaccinations administered in
outbreak situations (e.g., H1N1 vaccine, Ebola vaccine); (7) other very specific target groups (e.g., Roma
travellers, migrants, pregnant women; and (8) predisposing factors exclusively. We also excluded
qualitative studies and non-peer reviewed articles such as conference abstracts.
In case any doubt or disagreement between the two researchers who performed the study selection
(by L.D. and L.v.L.) arose, the specific papers were discussed in a plenary session with all co-authors.
2.3. Data Extraction
The following background characteristics from included studies were extracted: first author and
year of publication; study design; enrolment period; enrolment site; sample size; study population;
theoretical framework; and targeted outcome variables. Extracted data was collected in Microsoft
Excel 2016 and the presence and impact of determinants were rated in separate sheets per study group
(by L.D. and L.v.L.). Random samples were taken to check the data extraction and disagreements were
discussed plenary with all co-authors. Furthermore, the quality of studies was assessed using the the
AXIS tool [13], which is a screening tool specifically designed for cross-sectional studies, as those in
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our review, and includes 20 items relevant to this design. Scores 1–9 are rates as low, 10–14 as medium
and 15–20 as high.
2.4. Labelling of Determinants
The I-Change model was used to organize all determinants that could explain vaccination
uptake. A simplified version of this model is shown in Figure 1. The following concepts are used:
(1) predisposing factors, including baseline characteristics of studied populations; (2) information
factors, including information retrieved via media, social contacts and HCW; (3) awareness, of
the infectious agent being present or a vaccine being available; (4) knowledge (either examined or
self-evaluated), about the consequences of the infection, or about the efficacy and duration of protection
of vaccination; (5a) perceived risk of the infection, which is divided into perceived severity of the disease
and perceived susceptibility to get infected; (5b) perceived risk of vaccination, including vaccine-specific
considerations such as fear of side-effects and trust in the effectiveness of the vaccine; (6) attitude,
defined as a person’s disposition to respond favourably or unfavourably to vaccinations [14], often
reflected by a person’s general believes about vaccinations; (7) social influence, which can be social
norms imposed by family, friends or religion, but also recommendations from a healthcare professional
or tour guide; (8) self-efficacy, defined as beliefs in one’s own capacity to perform certain behaviour [15];
(9) intention to behaviour, expressed by people before they perform the behaviour; (10) barriers and
facilitators, that withhold individuals from or enable them to certain behaviour, such as time, costs,
or accessibility.
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3. Results
The literature search generated 2227 hits (Figure 2). After removing duplicates and excluding
articles published before 2010, 1260 articles were available on the topic. These were screened based
on title and abstract, resulting in 242 articles that were eligible for full-text assessment. These were
divided into the three subgroups (some were included in more than one category): 30 for travellers,
95 for ICP, and 122 for HCW. Finally, 17, 29, and 44 articles were included in the data analysis for the
three groups, respectively. The most common reason for exclusion was that no determinants (other
than predisposing factors) were reported. Table 1 describes the characteristics and quality of included
studies for travellers, ICP, and HCW. Determinants that play a role in vaccination uptake were retrieved
from the articles and summarized in Tables 2–4 for travellers, ICP, and HCW respectively. The results
of the quality assessment are presented in Supplementary Table S2.
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Table 1. Study characteristics of included studies for travellers, ICP and HCW.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Balaban, 2013
[16]
Pre- and
post-travel
surveys
2009 USA 186 American Hajj pilgrims None Seasonalinfluenza - Low
Barasheed,
2014 [17]
Cross-sectional
survey 2011–2012 Mina (Mecca) 966 Australian Hajj pilgrims None Influenza 62% High
Duffy, 2013
[18]
Cross-sectional
survey
2007
(Aug.–Sept.) United States 1691 American travellers to Asia None JE 11% Medium
Frew, 2017
[19]
Cross-sectional
survey
2015
(Feb.–March)
Ferry ports of 2
popular islands,
Thailand
1680
Backpackers from Europe,
Canada, Australia and
New-Zealand (94%)
None (KAP) HBV 31% completedseries High
Goodman,
2014 [20]
Online
cross-sectional
survey
2010 (Feb.) UK 302
Travellers to the meningitis
belt of Africa in last 3 years
or planned to do so next 6
months
None MenAWCY 30% Medium
Herbinger,
2011 [21]
Online
cross-sectional
survey
2009 (Dec.)
Netherlands, Czech
Republic, Spain,
Sweden
4203
Travellers to countries of
moderate or high prevalence
for HBV in the last 5 years
None HBV 39% in the previous5 years Medium
Heywood,
2016 [22]
Online
cross-sectional
survey
2014
(Aug.–Oct.)
Australia, Finland,
Germany, Norway,
Sweden, UK,
Canada
27,386
Travellers (18–65 years) who
travelled to HAV endemic
countries in Africa, Asia,
South/Central America in
the last 3 years
None HAV/HBV
27% for 3-dose
combined HAV and
HBV and 37% for
2-dose monovalent
HAV schedules
Medium
Igreja, 2019
[23]
Cross-sectional
survey
2019
(May–June)
Travel Clinic,
Lisbon, Portugal 55 Portuguese travellers None
Attitudes to
vaccinations
in general
- Low
Lammert,
2016 [24]
Retrospective
study 2012–2014
clinics from Global
TravEpiNet, USA 24,478
International travellers who
sought pre-travel health
advice
None
Refusal rates
of
recommended
vaccines and
reasons
25% refused one or
more recommended
vaccine(s)
High
Paudel, 2017
[25]
Prospective
enhanced
surveillance
study
2013
(Feb–2014
(Jan.)
Australia 180
confirmed cases of typhoid,
paratyphoid, measles, HAV,
HEV, chikungunya, malaria
None
Seeking
pre-travel
advice and
uptake
25% sought
pre-travel advice
and 16% got
vaccinated
Medium
Pavli, 2019
[26]
Cross-sectional
survey by
email
2015
(Nov.)–2016
(Mar.)
Greece 231
Greek (non-healthcare)
students from 36
universities, planning to
study abroad
None
Men,
intention to
vaccinate
23% vaccinated,
15% intention Medium
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Table 1. Cont.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Pfeil, 2010 [27]
2
cross-sectional
surveys
2009
(Jan.–Feb.),
2010 (Jan.)
Centre for Travel
Health, Zurich,
Switzerland
623 Travellers to aresource-limited destination None (KAP)
Seasonal (and
pandemic)
influenza
14% seasonal
influenza High
Selcuk, 2016
[28]
Cross-sectional
survey 2013 (July)
Istanbul Ataturk
Airport, Istanbul,
Turkey
124 Turkish travellers to A f rica None Recommendedfor destination
53% vaccinated
pre-travel Medium
Tan, 2017 [29] Retrospectivecohort study
2012
(Jan.)–2013
(Dec.)
Mayo Clinic Travel
and Tropical
Medicine Clinic,
Minnesota, USA
2073
Children and adults who
sought pre-travel advice
(19% VFR)
None
Documented
receipt or
positive
serology or
completion of
series
94% men in VFR,
12% rabies in VFR High
Tashani, 2016
[30]
Cross-sectional
survey 2014–2015
Immunization
clinic, Sydney,
Australia
300 Travellers (>18 year)planning to attend Hajj None
Pneu
and DTP when
recommended
17% pneu, 14% DTP Medium
Wiemken,
2015 [31]
Cross-sectional
study
2013
(Nov.)–2014
(July)
University of
Louisville, Travel
Clinic, USA
183 American travellers beforetheir consultation TPB
Intention to
get vaccinated Not given High
Yanni, 2010
[32]
Pre- and
post-travel
surveys
2008
(June–Sept.)
Departure lounges
at airports in New
York, Chicago, Los
Angeles, and San
Francisco
1301 (pre) (337
post)
American travellers who
will travel to Asia KAP Influenza 41% High
Akin, 2016
[33]
Cross-sectional
survey
2015
(July–Sep.)
Daycare
chemotherapy unit
of Hacettepe
University Cancer
Institute, Ankara,
Turkey
229 Adult patients with cancerreceiving chemotherapy None
Adult
vaccination
coverage
(influenza,
tetanus,
hepatitis,
pneu)
54% were
vaccinated at least
once, only 9% after
cancer diagnosis
Medium
Althoff, 2010
[34]
Nested
influenza
study
(interview
administered
surveys)
2006–2007 and
2007–2008 5 cities in the USA 1462 HIV+ women HBM Influenza
55–57% of women
reported
vaccination (about
44% not vaccinated)
Medium
Battistella,
2019 [35]
Cross-sectional
observational
study
2017
(Jan.–July)
7 large dialysis
services, Italy 703 Dialysis patients None Influenza 58% adherence High
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Table 1. Cont.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Chehab, 2018
[36]
Cross-sectional
study (in
longitudinal
cohort)
2012
(Nov.)–2013
(Oct.)
Germany 579 SLE patients (48% on IS) None
Influenza,
tetanus, pneu,
men and
previous
refusal
45% influenza (last
year); 65% tetanus;
32% pneu; 6% men
High
Chin-Yee, 2011
[37]
Cohort study
(one time
follow-up)
2009
(Oct.)–2010
(Mar.)
Tertiary care cancer
center, Canada 129
Patients with hematologic
malignancies (92%
chemotherapy, 76% in past 3
mo)
None
Seasonal
influenza (and
pandemic)
57% seasonal
influenza Medium
Gagneux-Brunon,
2019 [38]
Cross-sectional
survey Unknown France 468 HIV+ patients None
Pneu, HAV,
HBV, seasonal
influenza
30% IPD; 24% HAV;
64% HBV; 40%
influenza
Low
Haroon, 2011
[39]
Cross-sectional
survey (audit) 2009 (Sept.)
Outpatient clinics,
tertiary university
hospital, Ireland
110 Rheumatology patients on IS None
Seasonal
influenza and
pneu
34% influenza; 11%
pneu; 11% both Medium
Harrison, 2017
[40]
Cross-sectional
survey
2015
(Aug.–June)
HIV out-patient
department of the
University Hospital
of Vienna, Austria
455 HIV patients None Seasonalinfluenza 12% influenza Medium
Harrison, 2018
[41]
Cross-sectional
survey
2017
(July–Oct.)
Outpatient clinic,
Medical University
of Vienna, Austria
490 Inflammatory rheumaticdisease patients on IS None
Seasonal
influenza 25% influenza Medium
Lachenal,
2010 [42]
Cross-sectional
survey
(standardized
questionnaire)
2008 (Jan.) Centre Léon-Bérard,Lyon, France 200
Patients with haematological
malignancies (hospitalized
or at outpatient clinic)
None Influenza 26% Medium
Loubet, 2015
[43]
Self-reported
cross-sectional
survey
2013
(Summer)
AVNIR, a group of
associations whose
goal is to support
ICP, France
3653
79% autoimmune, 13% SOT,
8% treated for hematological
malignancies. 85% on IS.
KAP Influenza andpneu
59% seasonal
influenza and 49%
pneu
Medium
Loubet, 2018
[44]
Self-reported
cross-sectional
survey
2015
(Dec.)–2016
(March)
AFA, national
association of
patients with IBD,
France
199 IBD patients (62% receivingIS) KAP
Influenza and
pneu
34% influenza, 38%
pneu Medium
Malhi, 2015
[45]
Cross-sectional
survey
(self-reported,
paper-based)
2013
(Sept)–2014
(Jan.)
IBD Clinic or
Endoscopy Suite at
Mount Sinai
Hospital, Toronto,
Canada
305 IBD patients (53% usingbiologicals/steroids) None
Influenza,
pneu, HAV,
HBV, VZV,
men, HVZ,
HPV
61% influenza, 10%
pneu, 61% HBV,
52% HAV, 26% VZV,
21% men, 5% HZV,
11% HPV
High
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Table 1. Cont.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Miller, 2018
[46]
Cross-sectional
survey
2016
(June–Sept.)
3 tertiary
autologous and
allogeneic HSCT
centres, UK
93 HSCT patients (79%autologous) adjusted HBM
Intention to
receive
seasonal
influenza
76% expressed high
intent High
Mouthon,
2010 [47]
Cross-sectional
survey
(standardized
questionnaires)
2006 and 2007
Dept. Of Internal
Medicine, Cochin
Hospital, France
177 Patients with systemicsclerosis None Influenza 39% (last year) Medium
Narula, 2012
[48]
Cross-sectional
survey
2010
(May–Aug.)
McMaster
University Medical
Centre Digestive
Disease Clinic,
Canada
250 IBD patients (63% on IS) None
Seasonal (and
H1N1)
influenza
25% seasonal
influenza High
Nguyen, 2017
[49]
Cross-sectional
survey with
invitation
RCT for new
pneu vaccine)
2014
(Oct.–Nov.)
Outpatients clinic
of rheumatology at
2 hospitals in
Graasten, Denmark
192 RA patients None Influenza andpneu
59% seasonal
influenza ever, 49%
last year, 6% pneu
High
Poeppl, 2015
[50]
Cross-sectional
survey
2013
(July)–2013
(Oct.)
Outpatient
departments of the
General Hospital
Vienna, Austria
444
Patients with malignancies
(55% solid tumours, 22%
haematological malignancy,
and 17% had no diagnosed
malignancy)
None Influenza 18% influenza lastyear Medium
Price, 2019
[51]
Cross-sectional
survey
2014
(June–July)
Cancer center
providing
ambulatory care,
USA
703
Patients (83%) (and
caregivers and family (17%)
of patients) treated for
malignancies
None Influenza
Patients 72%,
caregivers 71% (last
year)
Medium
Restivo, 2017
[52]
Prospective
observational
study
2014
(Oct.)–2015
(April)
SOT Reference
Center in Palermo,
Sicilia, Italy
82
SOT recipients during
hospital admission for
transplantation
None Influenza 38% Medium
Ruiz-Cuesta,
2016 [53]
Prospective
observational
study
2012
(Jan.–March)
Reina Sofía
University Hospital,
Córdoba, Spain
153
IBD (50% UC, 50% CD)
patients (>14 years old), 34%
on
biologicals/corticosteroids
None
HAV, HBV,
VZV, MMR
assessed by
registry
84% Medium
Sadlier, 2015
[54]
Retrospective
study, with
provider-delivered
survey
2014
(Jan.–Feb.)
Tertiary university
hospital in Ireland 170
Dermatology patients
prescribed systemic IS None
Influenza and
pneu
38% seasonal
influenza last year,
21% pneu last 5
years, 18% both.
Medium
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Table 1. Cont.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Sandler, 2016
[55]
Cross-sectional,
telephone
survey
2013
(July–Sept.)
Memorial Medical
Center in Chicago,
USA
102 RA patients (85–91% takingIS) None
Self-reported
and EHR
influenza,
pneu, and
HZV
79% influenza last
season, 54% pneu
and 8% HZV
High
Savage, 2011
[56]
Retrospective
audit
2010
(Aug.–Oct.)
Outpatient
dermatology clinics
in Aberdeen
RoyalInfirmary,
Scotland
87 Immunocompromiseddermatology patients None
Influenza and
pneu
70% influenza (last
year), 22% pneu Medium
Struijk, 2015
[57]
Cross-sectional
survey Unknown
Renal Transplant
Unit, Academic
Medical Center,
Amsterdam, NL
526
77% renal transplant
recipients (and their
nephrologists)
KAB
Influenza,
tetanus,
pneumococci,
HAV, HBV
56% influenza,
15–30% tetanus,
0–5% pneu, 5–30%
HAV, 10–20% HBV
High
Teich, 2011
[58]
Cross-sectional
survey
2009
(April–Sept.) Germany 203
IBD patients who had not
received vaccination
counseling ≥1 year (54% on
IS)
None Vaccinationsin general
67% tetanus (<10
years), 21%
pertussis, 28%
seasonal influenza,
9% pneu
High
Urun, 2013
[59]
Cross-sectional
survey (with
face-to-face
interviews)
2012
(Jan.–March)
Medical Oncology
Department of
Ankara University
Faculty of Medicine,
Turkey
359 Patients with malignancies None Influenza andpneu
17% influenza 4%
pneumococcal Medium
Waszczuk,
2018 [60]
Cross-sectional
survey
(self-completed)
Unknown Wrowclaw, Poland 195 IBD patients (70% on IS) None
Influenza,
HBV and
pneu
HBV 55%; Tdap
12%; HAV 7%;
annual influenza
6%; VZV/HZV 3%,
and pneu 2%
High
Wilckens, 2011
[61]
Cross-sectional
survey
2009
(April–Oct.)
IBD outpatients’
clinic, a tertiary
referral center,
Lueneburg,
Germany
102 IBD patients (57% CD, 91%on IS) None
Vaccinations
in general
19% influenza, 3%
pneumoccous, 22%
HBV, 5% VZV, 55%
MMR, and 63%
tetanus. Of those
who had traveled,
9% HAV and 1% YF
High
Akan, 2016
[62]
Cross-sectional
study
2014
(June–Sept.)
family health care
centres in Turkey 596 GPs
used, name
not mentioned
Seasonal
influenza 27% High
Asma, 2016
[63]
Cross-sectional
study 2015 (Jan.)
6 university
hospitals in Turkey 642
177 (28%) physicians and
448 (71%) nurses None
Seasonal
influenza 9% Medium
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Table 1. Cont.
Study Study Design EnrolmentPeriod Enrolment Site Sample Size Study Population
Theoretical
Framework
Outcome
Measures *
Vaccination
Coverage Quality Score **
Boey, 2018 [64] Cross-sectionalstudy
2015
(Nov.–Dec.)
13 hospitals and 14
nursing homes in
Belgium
5141 4506 hospital staff, 635 HCWnursing home staff.
HBM, HIM
and ASE
Seasonal
influenza
2014: 62% (hospital)
2015: 65% (hospital) High
Bonaccorsi,
2015 [65]
Cross-sectional
study
2010
(Oct.–Nov.)
Careggi University
Teaching Hospital,
Florance, Italy
2576
10% physicians, 39% nurses,
23% students, 4% health care
assistant, 15% other
None Seasonalinfluenza 18% Medium
Castilla, 2013
[66]
Cross-sectional
study
2012
(Mar.–May)
PHC workers,
Spain 1956
47% GP, 10% paediatricians,
43% nurses None
Seasonal
influenza 52–61% (2008–2011) High
Ciftci, 2018
[67]
Cross-sectional
study
2015
(Sept.–Dec.)
University Hospital,
Ankara, Turkey 470
Tertiary healthcare setting
(18% physicians, 29% nurses,
11% assistants, 23%
auxillary, 9% paramedics,
10% secretaries)
None Seasonalinfluenza 27% High
Costantino,
2019 [68]
Cross
sectional
study
Influenza
seasons
2016–2019
University Hospital
of Palermo, Italy 1237
Hospital HCW that had not
received influenza
vaccination
None Seasonalinfluenza 0% High
Dedoukou,
2010 [69]
Cross-sectional
study
2018
(Oct.–Nov.) 76 PHCs in Greece 1617
PHC: 35% physicians, 32%
nurses, 23%
paramedical/technical, 8%
administrative
None Seasonalinfluenza 41% Medium
deSante, 2010
[70]
Cross-sectional
study 2009 (Apr.)
2 tertiary care
hospitals in
Pennsylvania, USA
227
House officers and
attending physicians in
emergency/internal
medicine depts.
None Seasonalinfluenza 94% Medium
Dominguez,
2013 [71]
Cross-sectional
study
2012
(Mar.–May)
PHC workers in 7
Spanish regions 1749
Familiy physician (47%),
paediatrician (10%), nurses
(43%).
None Seasonalinfluenza 51% High
Durando,
2016 [72]
Cross-sectional
study
2013
(Oct.)–2014
(Apr.)
San Martino
Teaching
Hospital/Scientific
Research Institute,
Italy
830 HCW None Seasonalinfluenza 26% High
Ehrenstein,
2010 [73]
Cross-sectional
study 2006 (Feb.)
Tertiary care
university hospital
in Germany
652
HCW (physicians 36%,
nurses 42%, administrators
22%)
None Seasonalinfluenza 34% Medium
Giese, 2016
[74]
Cross-sectional
study 2013 Ireland 164
HCW in a study group of
Irish residents None
Seasonal
influenza 28% Medium
Gramegna,
2018 [75]
Cross-sectional
study 2016 Italy 144
Italian Respiratory Society
members
Seasonal
influenza 55% Medium
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Gutknecht,
2016 [76]
Cross-sectional
study
2016
(Feb.–Mar.) Poland 77 Physicians None
Seasonal
influenza - Low
Hagemeister,
2018 [77]
Cross-sectional
study
2015
(June-July)
University Hospital
Würzburg,
Germany
677 Physicians and nursing staff None Seasonalinfluenza 55% Medium
Harrison, 2016
[78]
Cross-sectional
study -
Vienna General
Hospital, Austria 116 Nursing staff None
HAV/HBV,
DTP/Tdap,
MMR,
influenza,
VZV, men,
pneu
Seasonal influenza:
42%; Measles: 60% Medium
Hopman, 2010
[79]
Cross-sectional
study
2008
(Nov.–Dec.)
All 8 University
Medical Centers in
NL
1238 HCW at medium and highrisk for influenza
HBM, BIM,
ASE
Seasonal
influenza 38% Medium
Hulo, 2017
[80]
Cross-sectional
study 2014
University Hospital
Lille, France 344
HCW in the emergency
departments and the IC
units
None Seasonalinfluenza 18% Medium
Johansen,
2012 [81]
Cross-sectional
study 2007 (May)
North and South
Dakota 155
Randomly selected nurses
(52% hospital, 13% clinic,
12% long term)
Triandis Seasonalinfluenza - Medium
Kalemaki,
2020 [82]
Cross-sectional
study - Crete, Greece 260 GPs None
Seasonal
influenza,
measlesHBV,
Tdap
Seasonal influenza
57%; Measles 26%
HBV 68%; Tdap
47%
High
Karlsson, 2019
[83]
Cross-sectional
study -
Public hospitals in
Finland 2962
Hospital personnel who
may work with vaccinations
(14% physicians)
None Seasonalinfluenza - High
Kisic-Tepavcevic,
2017 [84]
Cross-sectional
study 2015 (Dec.)
Clinical Centre of
Serbia, Belgrade,
Serbia
352 HCW None HBV 66% High
Lehmann,
2015 [85]
Cross-sectional
study
2013
(Feb.–Apr.)
20 hospitals in
Belgium, Germany
and NL
1022 56% nurse, 15% physicians,14% paramedics None
Seasonal
influenza
Total: 37%;
Netherlands: 28%;
Belgium: 53%;
Germany: 36%
High
Maridor, 2017
[86]
Cross-sectional
study 2013
3 medium-sized,
non-teaching
hospitals,
Switzerland
252 Nursing staff None Seasonalinfluenza 58% Medium
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Napolitano,
2019 [87]
Cross-sectional
study
2018
(Sept.–Nov.) 8 hospitals in Italy 531
Random sample of HCWs
(29% physicians, 59%
nurses)
None
HBV,
influenza,
MMR, VZV,
pertussis
HBV: 98%; DTP:
91%; MMR: 64%;
VZV: 59%; TBC:
50%; Influenza:
30%; Men C: 41%
High
Nowrouzi,
2014 [88]
Cross-sectional
study
2011
(Sept.–Nov.)
University of
Toronto 963
Medical trainee’s (post
graduate) HBM
Seasonal (and
pandemic)
influenza
Seasonal influenza
69–76% (2008–2010) High
Pielak, 2010
[89]
Cross-sectional
study 2005 (Apr.)
British Columbia,
Canada 719
Immunization nurses of all
health units and all
physicians that administer
vaccinations
TPB Seasonalinfluenza - High
Prematunge,
2014 [90]
Cross-sectional
study 2010 (June)
Tertiary care
hospital Ontario,
Canada
3275
35% nurse, 5% physician,
11% allied HCW’s, 22%
administrative/clerical
None
Seasonal (and
pandemic)
influenza
Seasonal influenza:
74% Medium
Quan, 2012
[91]
Retrospective
cohort study 2006–2011
University of
California Irvine
Healthcare
32,808 all HCWs None Seasonalinfluenza 44–92% (2007–2011) Medium
Rabensteiner,
2018 [92]
Cross-sectional
study
2016
(Oct.–Dec.)
South Tyearolean
Health Service, Italy 4091
13% physicians, 20%
administrative, 67% sanitary
or executive non-medical
staff
None Seasonalinfluenza 10% High
Real, 2013 [93] Cross-sectionalstudy -
Academic medical
center in Lexington,
USA
318 80% clinical, 20%non-clinical RPA
Seasonal
influenza
66% already
received the
vaccination or
planned to get one
soon
Medium
Rebmann,
2012 [94]
Cross-sectional
study
2011
(Apr.–June)
Saint Louis region,
USA 3188
54% non-hospital HCW, 46
% hospital HCW None
Seasonal (and
pandemic)
influenza
2010/11: 79% High
Scatigna, 2017
[95]
Cross-sectional
study
2015
(Apr.–May)
San Salvatore
Hospital, L’Aquila,
Italy
334 Nurses 53%, physicians 23%,other 24% None
HBV,
influenza,
MMR, VZV
- Medium
Surtees, 2018
[96]
Cross-sectional
study 2016
Tertiary referral
hospital in Victoria,
Australia
1835 HCW None Seasonalinfluenza 97% High
Taddei, 2014
[97]
Cross-sectional
study
2011
(June–Oct.)
6 public hospitals in
Florence, Italy 436
59% nurses, 21% physicians,
13% nursing assistants, and
7% were midwives
None MMR, VZV,Pertussis
11% measles, 7%
mumps, 17%
rubella, 2% VZV, 7%
pertussis
Medium
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Tanguy, 2011
[98]
Cross-sectional
study
2009
(Nov.)–2010
(Feb.)
Tertiary care centre
in Pays de la Loire
Region, France
532
24% medical staff, 65%
nursing staff, 11% ancillary
staff
None
Seasonal (and
pandemic)
influenza
22% Medium
Vallée-Tourange,
2018 [99]
Cross-sectional
study
2014
(June–July)
A single
metropolitan
hospital group, UK
784
11% physicians, 36% nurses,
30% allied health
professionals, 17% assistants
CME Seasonalinfluenza - Medium
Verger, 2016
[100]
Cross-sectional
study
2014
(Apr.–July) France 1582 GPs None
Seasonal
influenza,
DTP, HBV
72% influenza, 84%
DTP, 86% HBV High
Virseda, 2010
[101]
Cross-sectional
study
2009
(Dec.)–2010
(Jan.)
University Hospital
12 de Octubre,
Madrid, Spain
527
HCW (23% physician, 29%
nurse, 19% nursing assistant,
29% ancillary staff)
None
Seasonal (and
pandemic)
influenza
50% Medium
Wicker, 2010
[102]
Cross-sectional
study
2010
(Jan–May)
Frankfurt
University Hospital,
Germany
1504
Physicians 26%, nurses 35%,
other HCW 23%, students
16%
None Pertussis 22% in last 10 years Medium
Wilson, 2019
[103]
Cross-sectional
study
Influenza
seasons
2015–2017
Southeast France 1539 74% hospital nurses, 26%community nurses None
Seasonal
influenza
Both seasons: 24%
at least one season:
34%
Medium
Wilson, 2020
[104]
Cross-sectional
study 2017–2018 Southeast France 1539
74% hospital nurses, 26%
community nurses None
Mandatory
and
recommended
vaccines in
France
96% BCG, 73% DTP
(<10 years), 61%
HBV, 58% pertussis,
64% measles, 39%
VZV, 27% seasonal
influenza (last year)
Medium
Zhang,
2011 [105] and
2012 [106]
Cross-sectional
study
2010
(May-Oct.)
University Hospital
London 522
Qualified nurses (79%
working in hospital None
Seasonal
influenza 36% Medium
* concerns vaccination uptake unless otherwise specified. ** Quality is assessed with the AXIS tool. A low score represents fulfillment of 1–9 out of 20 items, medium 10–14 and high
15–20 items (Exact scores are given in Supplementary Table S2). The following abbreviations are used (organized per column, in alphabetical order): Enrolment sites: USA = United States of
America; UK = United Kingdom; NL = the Netherlands. Study populations: CD = Crohn’s Disease; GP = general practitioner; HCW = healthcare workers; HIV = human immunodefiency
virus; HSCT = hematological stem cell transplantation; IBD = inflammatory bowel disease; ICP = immunocompromised patients; IS = immunosuppressive treatment; PHC = primary
healthcare; RA = rheumatoid arthritis; SOT = solid organ transplantation; UC = colitis ulcerosa; VFR = travellers visiting friends and relatives. Theoretical frameworks: ASE = attitude,
social influence and self-efficacy model; HBM = health belief model; KAP = knowledge, attitude, practice; HIM = the Health Intention Model; BIM = behavioral intention model; CME =
Cognitive model of empowerment; RPA = risk perception attitude framework; Triandis = Triandis model of interpersonal behavior. Vaccinations: BCG = Bacillus Calmette-Guerin (vaccine
for tuberculosis); DTP = diphtheria, tetanus, poliomyelitis; HAV = hepatitis A virus; HBV = hepatitis B virus; HZV = herpes zoster virus; JE = Japanese encephalitis; Men = meningococcal
disease; menACWY = meningococcal serotype A, C, W and Y; MMR = measles, mumps, rubella; Pneu = pneumococcal disease; TBC = tuberculosis; Tdap = tetanus, diphtheria, acellular
pertussis; VZV = varicella zoster virus, YF = yellow fever.
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Table 2. Overview of determinants of vaccination uptake in travellers.
Characteristics and Determinants [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] * [32]
Type of travellers
Hajj x x x
VFR x x
Backpackers x
VPD
Influenza x x x x x x x
Men x x x x x
Pneu x x x
HAV x x x x x
HBV x x x x x x
DTP/Tdap x x x x
MMR x x x
VZV/HZV x x
YF x x x
JE x x x
Rabies x x x
Typhoid fever x x x
Vaccines in general x x
Determinants
Predisposing factors
Age ↓ = ↓ ↓ ↑ = = = ↑
Gender: male = = = = = =
Education level = ↑ ↑
Travel purpose: VFR = ↓ = ↓
Travel purpose: business ↑ ↓
Travel duration = = ↓ = ↓ ↑
Information factors
Internet ‹ ‹ ‹ ‹ ‹ «
TV/radio ‹
Primary HCW (GP) ‹ ‹ ‹ ‹ « ‹ « «
Specialist HCW (travel clinic) ‹ ‹ ‹ ‹ ‹
Family/friends ‹ ‹ ‹ ‹ ‹ ‹
Travel organization « ‹
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Table 2. Cont.
Characteristics and Determinants [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] * [32]
Cognitive determinants
Awareness ‹ « « « « ‹
Perceived knowledge = ↑ « ↑ «
Perceived risk of infection ↑ ‹ ‹ = « « = « « «
Perceived risk of vaccination « ‹ « ‹
Attitude ‹ = ‹ « « =
Social Influence/norm « ‹ « « ‹ « =
Self-efficacy
Intention to behaviour =
Barriers
Costs ‹ ‹ = ‹
Time ‹ ‹
Promotors
Reminder ‹
The following symbols are used: x applicable; = no significant difference; ↑ significant positive association (tested by multivariate analysis); ↓ significant negative association (tested
by multivariate analysis); ↑ significant positive association (tested by chi-square, univariate analysis or correlation coefficient); ↓ significant negative association (tested by chi-square,
univariate analysis or correlation coefficient); « (double caret pointing upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥50% of the
population; « (double caret pointing downwards) significance was not tested, but determinant was negatively linked to vaccination uptake in ≥50% of the population; ‹ (caret pointing
upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥10% of the population; ‹ (caret pointing downwards) significance was not tested, but
determinant was negatively linked to vaccination uptake in ≥10% of the population. * determinants were studied in relation to intention to be vaccinated instead of vaccination uptake.
The following abbreviations are used (in alphabetical order): CD = Crohn’s Disease; DTP = diphtheria, tetanus, poliomyelitis; GP = general practitioner; HAV = hepatitis A virus; HBV =
hepatitis B virus; HCW = healthcare workers; HIV = human immunodefiency virus; HSCT = hematological stem cell transplantation; HZV = herpes zoster virus; IBD = inflammatory
bowel disease; IS = immunosuppressants; JE = Japanese encephalitis; Men = meningococcal disease; MMR = measles, mumps, rubella; Pneu = pneumococcal disease; Tdap = tetanus,
diphtheria, acellular pertussis; SOT = solid organ transplantation; VFR = travellers visiting friends and relatives; VZV = varicella zoster virus; YF = yellow fever.
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Table 3. Overview of determinants of vaccination uptake in ICP.
Characteristics and Deterrminants [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61]
Risk groups
Auto-immune (IS treatment) x x x x x x x x x x x x x x x x
HIV x x x
Solid tumors x x x x
HSCT x x x x x x
SOT x x x
Vaccines
Influenza x x x x x x x x x x x x x x x x x x x x x x x x x
Pneu x x x x x x x x x x x x x
Men x x
HBV x x x x x
HAV x x x x
DTP/Tdap x x
MMR x
VZV/HZV x x x
Vaccines in general x x x
Determinants
Predisposing factors
Age = ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ = = ↓ ↑ ↑ ↑ ↑ ↑ = ↑ = = ↑
Male gender = ↑ = = ↑ = = = = = = = = ↑ =
Education level ↓ = ↓ = = = = = ↑ = = = = =
Use of (strong) IS ↑ ↑ ↓ ↑ ↑ ↓ = ↑ = =
Comorbidities = ↓ ↑ ↑ ↑ = ↑
Vaccination history ↑ ↑ ↑ ↑ ↑
Information factors
Internet/social media ↓ = = ‹ =
TV/radio ↑ = =
HCW: GP ↑ ↑ ↑ ‹ « ↑ « ‹
HCW: specialist ↑ ↑ ↑ ↑ ↑ ↑ « ‹ ↑ ↑ ↑ ‹ «
Family/friends = = ‹
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Table 3. Cont.
Characteristics and Deterrminants [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61]
Cognitive determinants
Awareness « « ↑ ↑ « « ‹ ‹ ‹ ‹ = ‹ « « ‹ ‹ «
Perceived knowledge = « ↑ ↑
Perceived risk of infection ‹ = = ‹ ‹ ‹ « ↑ ‹ ‹ ‹ « « ↑
Perceived risk of vaccination ‹ ↓ ‹ ‹ ‹ ‹ ‹ « ‹ ‹ ↓ ‹ ‹ ‹ ‹ ‹ ‹ ‹ ↓ ‹ ‹
Attitude « ‹ ‹ ‹ ‹ ↑ ↑ ‹ ‹ ‹ « ‹ = ‹
Social influence/norm ↑ ↑ ‹ ‹ ‹ ↑
HCW recommendation ↑ ↑ ↑ ↑ ↑ « « ↑ ↑ ↑ ‹ «
Self-efficacy ↑ ‹
Intention to behaviour « « =
Barriers
Costs ↓
Time (before start therapy) ‹ ‹
Inconvenience ‹ ‹ = ‹
Promotors
Reminder ↑ ‹ ‹
Annual vaccine check ↑
Recent healthcare visit ↑
The following symbols are used: x applicable; = no significant difference; ↑ significant positive association (tested by multivariate analysis); ↓ significant negative association (tested
by multivariate analysis); ↑ significant positive association (tested by chi-square, univariate analysis or correlation coefficient); ↓ significant negative association (tested by chi-square,
univariate analysis or correlation coefficient); « (double caret pointing upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥50% of the
population; « (double caret pointing downwards) significance was not tested, but determinant was negatively linked to vaccination uptake in ≥50% of the population; ‹ (caret pointing
upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥10% of the population; ‹ (caret pointing downwards) significance was not tested,
but determinant was negatively linked to vaccination uptake in ≥10% of the population. The following abbreviations are used (in alphabetical order): CD = Crohn’s Disease; DTP =
diphtheria, tetanus, poliomyelitis; GP = general practitioner; HAV = hepatitis A virus; HBV = hepatitis B virus; HCW = healthcare workers; HIV = human immunodefiency virus; HSCT =
hematological stem cell transplantation; HZV = herpes zoster virus; IBD = inflammatory bowel disease; IS = immunosuppressants; JE = Japanese encephalitis; Men = meningococcal
disease; MMR = measles, mumps, rubella; Pneu = pneumococcal disease; Tdap = tetanus, diphtheria, acellular pertussis; SOT = solid organ transplantation; VFR = travellers visiting
friends and relatives. VZV = varicella zoster virus, YF = yellow fever.
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Table 4. Overview of determinants of vaccination uptake in HCW.
Characteristics and
Determinants [63] [62] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] * [100] [101] [102] [103] [104] [105,106]
VPD
Influenza x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
HBV x x x x x x
DTP/Tdap x x x x x x
MMR x x x x x x
VZV/HZV x x x x
Vaccines in general x x
HCW
Physician x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Nurses x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Other HCW x x x x x x x x x x x x x x x x x x x x x x x
Determinants
Predisposing factors
Age ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ = ↓↑ ↑ ↑ = ↓↑ ↓ ↑ = ↑ = ↓ = ↑ ↑ ↑ ↑ ↑ ↑ =
Gender: male ↑ = ↑ ↑ ↑ ↓ ↑ ↑ ↑ = ↑ ↓ = = = ↓ ↓ ↑ = ↓ ↑ = = ↑ ↑ ↑ =
Education level ↑ ↑ ↑ ↑ =
Occupation: physician ↑ ↑ ↑ ↑ ↑ ‹ ↑ ↑ ‹ ↑ ↑ ↑ ↑ ↑ = ↑ ↑ = ↑ ↑
Work experience (years) ↑ ↑ ↑ ↑ ↑ = ↓ ↑ =
Chronic disease ↑ ↑ ↑ ↑ ↑ = ↑ = = ↑
Children living at home = = ↑ = ↑ = = ↓ =
Vaccination history ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑
Information factors
Social media ↓ ↓
TV/Radio ↓
Evidence-based sources ↑ ↑ ↑ ↑ ↑
Collegues ↑
Cognitive determinants
Awareness
Knowledge = = ‹ = ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ = ↑ ↑ ‹ ↑
pRisk of infection (S) ↑ ↑ ↑ ↑ « ‹ « « ↑ ↑ « ‹ « « ‹ « ↑ « ‹ ↑ ↑ ↑ « ‹ ‹ = = ‹ ‹ « ↑ « « ↑ ↑
pRisk of infection (P) ↑ ↑ ↑ ‹ ‹ « ↑ ↑ « ‹ ‹ ↑ « ‹ « ‹ « ‹
pRisk of vaccination ↓ ↓ ↓ ↓ « ‹ ‹ ↓ ↓ ‹ ‹ ‹ « ↓ ‹ ↓ ‹ ↓ = ↓ « ‹ ‹ ‹ ↓ ↓ ‹ ‹ ↓ « ‹ ↓ ↓ «
Attitude ↑ ↑ ↑ ↑ « ‹ ‹ ↑ ‹ ↑ ‹ ↑ ↑ « ↑ ‹ ‹ ↑ « ‹ ↑ ‹
Social Influence ↑ ↑ ↑ = ‹ ‹ ↑ ↑ ‹ ↑ ‹ ↑ ‹ ↑ ‹
Professional norm ↑ ↑ ↑ ↑ ↑ « ↑ ↑ ↑ « ‹ ↑ ↑ ↑ ‹
Self-efficacy ↑ ↑ = ↑ ↑ ‹ ↑
Intention to behaviour ↑ ↑ « ↑
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Table 4. Cont.
Characteristics and
Determinants [63] [62] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] * [100] [101] [102] [103] [104] [105,106]
Barriers ‹
Costs ↓ ‹
Time ‹ ‹ ‹ ‹ ‹ ‹ ‹
Promotors
Reminder ↑ ↑ ↑
Convenient place/time ↑ ↑ « ↑
Reward ↑ ↑ ↑
* One scale (MoVac-flu scale) was used for following determinants: knowledge, attitude and self-efficacy. The following symbols are used: x applicable; = no significant difference; ↑
significant positive association (tested by multivariate analysis); ↓ significant negative association (tested by multivariate analysis); ↑ significant positive association (tested by chi-square,
univariate analysis or correlation coefficient); ↓ significant negative association (tested by chi-square, univariate analysis or correlation coefficient); ↓↑ significant association, for one
vaccine positive, for the other negative; « (double caret pointing upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥50% of the
population; « (double caret pointing downwards) significance was not tested, but determinant was negatively linked to vaccination uptake in ≥50% of the population; ‹ (caret pointing
upwards) significance was not tested, but determinant was positively linked to vaccination uptake in ≥10% of the population; ‹ (caret pointing downwards) significance was not tested, but
determinant was negatively linked to vaccination uptake in ≥10% of the population. pRisk = perceived risk. pRisk of infection (S/P): S = self; P = patient. The following abbreviations
are used (in alphabetical order): CD = Crohn’s Disease; DTP = diphtheria, tetanus, poliomyelitis; GP = general practitioner; HAV = hepatitis A virus; HBV = hepatitis B virus; HCW
= healthcare workers; HIV = human immunodefiency virus; HSCT = hematological stem cell transplantation; HZV = herpes zoster virus; IBD = inflammatory bowel disease; IS =
immunosuppressants; JE = Japanese encephalitis; Men = meningococcal disease; MMR = measles, mumps, rubella; Pneu = pneumococcal disease; Tdap = tetanus, diphtheria, acellular
pertussis; SOT = solid organ transplantation; VFR = travellers visiting friends and relatives. VZV = varicella zoster virus, YF = yellow fever.
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3.1. Vaccination Uptake Among Travellers
The 17 articles that studied determinants of vaccination uptake among travellers comprised
12 cross-sectional surveys, two pre- and post-travel surveys, and three retrospective studies of which
one was based on confirmed cases of VPD (Table 1). Travellers that were studied originated from the
USA (6 studies), Australia (4 studies), Europe (5 studies), or mixed continents (2 studies). Sample
sizes ranged from 55 to 27,386 and comprised Hajj pilgrims in three studies, travellers to Africa in two
studies and to Asia in two studies. Other studies had broader inclusion criteria. Three studies used
KAP (knowledge-attitude-practices) surveys and one study mentioned a health behavioural model
(theory of planned behaviour) as theoretical background for their study.
3.1.1. Predisposing Factors
Ten articles studied baseline characteristics of travellers that could be associated with vaccination
uptake (Table 2). The vaccinations that were studied were diverse, most papers discussed vaccinations
for influenza (n = 7), hepatitis B virus (HBV) (n = 6), hepatitis A virus (HAV) (n = 5) and meningococcal
disease (n= 5). Regarding age, three papers reported that younger people had a higher uptake [18,20,24].
However, for influenza vaccination this was the opposite: older travellers were more likely to be
vaccinated for seasonal influenza [27,32]. Gender was not a significant predictor of vaccination
uptake in any of the studies. Education level was studied by three papers [18,27,31]. Two found this
determinant to be positively associated with (intention to) obtaining recommended vaccinations [28,31].
Seven studies reported travel purpose in relation to vaccination uptake, but the results were diverse.
One study concluded vaccination uptake was highest if the reason of travelling was business or
backpacking [20]. However, work-related travel was associated with lower uptake in another study
(OR = 0.39, (0.17–0.92)) [27]. Travellers visiting friends and relatives (VFR) had a lower uptake in two
studies [24,29], but two other studies found no association [20,25]. Six papers studied the relation
between travel duration and vaccination uptake. Two studies showed that uptake was significantly
lower when people travelled longer [24,28], while one found that it was higher (for rabies only) [29]
and three studies found no difference [19,20,27].
3.1.2. Information Factors
No clear relationship between information sources and vaccination uptake was reported. However,
eight studies reported a role for the GP, of which three said that the GP was very influential [22,29,30,32].
3.1.3. Cognitive Determinants
Of all the cognitive determinants studied, perceived risk of infection was most frequently described
in relation to vaccination uptake (n = 10). Only one study found a significant positive relation (OR 1.74
(95% CI 1.14–2.62)) [16], and another five reported this factor to play a role in the majority of the
study population. Although not often tested for significance, “not feeling at risk of the disease” was a
common explanation of a lot of travellers for not receiving the recommended vaccinations. Perceived
risk of vaccination was sparsely discussed (n = 4).
Social influence, which comprises mostly trust and recommendations of healthcare providers in
this selection of studies, was reported in seven papers and was recognised as important by the majority
of the study population in four papers.
Attitude was described in six papers, and was not found to be significant in two of them [19,31];
reliance on natural immunity was mentioned three times as a reason to reject vaccination [17,23,30].
Awareness was also discussed in six papers; although it was not tested for significance, 13–73%
mentioned unawareness of the availability of the vaccination (or unawareness of the recommendation
of the vaccination) as an important reason for non-uptake [17,18,20–22,30].
Five studies reported on knowledge of VPD; two found a significant positive relation between
knowledge and vaccination uptake [20,26], one found no relation [19].
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3.1.4. Barriers and Facilitators
Reported barriers could be classified in costs and lack of time. Costs were the most described;
however, it played a modest role in explaining non-uptake and differed per vaccination. For instance,
for influenza vaccination uptake costs were mentioned to play a role in less than 7% of travellers, while
for HBV (12%), Japanese encephalitis (35%) and pneumococcal vaccination (38%) concerns about costs
were much higher. In two papers lack of time was given as part of the explanation of non-uptake in
more than 10% of the study population [17,22]. One paper described that 3–24% of travellers require a
reminder to complete their vaccination series [22].
3.2. Vaccination Uptake among Immunocompromised Patients
Twenty-nine articles concerning ICP were included. Most of these studies were cross-sectional
(n = 23), but four were prospective (with a follow-up moment) and two retrospective (Table 1). Studies
were performed among European (n = 23), American (n = 3) and Canadian (n = 3) populations. Sixteen
studies involved patients with auto-immune diseases, of which four studies focussed completely on
patients with inflammatory bowel disease. The vaccination uptake of HIV patients was studied in
three papers. Four papers studied populations with solid tumours, six papers studied patients who
received haematological stem cell transplantation (HSCT) and three papers investigated patients who
received a solid organ transplantation (SOT). Almost all papers addressed the influenza vaccination
uptake (n = 25) and many also included the uptake of pneumococcal vaccinations (n = 13). Influenza
vaccination rates varied from 6–79% and pneumococcal vaccination rates from 2–54%. Lowest rates
were reported in Polish inflammatory bowel disease (IBD) patients [60] and highest in American
rheumatic patients [55]. In ICP, health behaviour models were cited slightly more than in the travellers
population. Two studies were based on the (HBM) and another three studies used KAP surveys.
3.2.1. Predisposing Factors
Most studies (17 out of 24 that studied age) found a positive association between age and
vaccination uptake (Table 3). Especially for influenza vaccination, older patients tend to be more
compliant with vaccination guidelines in the studied year. Only in one study a negative association
was found (OR 0.02, 95% CI (0.01–0.57)) [46]. Most studies report that gender and education level are
not significant predictors of vaccination uptake in ICP, with a few exceptions. Three studies showed in
a multivariate analysis that males had a higher uptake. Two studies showed a negative association
between uptake and education level, while one showed a positive association. In five studies, the
use of strong immunosuppressive medication was positively associated with vaccination uptake,
whereas in two studies the association was negative and in three there was no association. Generally,
ICP with comorbidities in their medical history tend to have a higher uptake in four [38,39,42,54]
out of seven studies. One study reported a negative association [42] and two found no significant
difference [33,52]. All five papers that included vaccination history (for the same or another vaccination),
concluded that there was a positive association between vaccination uptake in the past and current
uptake [34,43,46,47,52].
3.2.2. Information Factors
Thirteen studies investigated where ICP retrieve their information from. In general, gathering
information from online media sources was somewhat associated with a lower vaccination uptake,
while receiving information from HCW resulted in a higher uptake [35,41].
3.2.3. Cognitive Determinants
Perceived risk of vaccination was the most frequently mentioned cognitive determinant, being
discussed in 21 of the 29 articles. In all three papers that tested for significance, a negative correlation
with vaccination uptake was found, meaning that a higher perceived risk of a vaccine results in a lower
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uptake. But also that a lower perceived risk, reflected for example by trust in the effectivity of this
specific vaccine, increases the uptake. Fear for side-effects or deterioration of their disease caused by
the vaccination were mentioned often. Another concern that was often expressed was the doubt of
effectivity of vaccination, due to either the immunogenicity of the vaccine or due to the compromised
state of the patients’ immune system. Distrust was reported more often for influenza than for other
vaccinations [55].
Awareness of either the availability of or the indication for a vaccination was also widely discussed
(n = 17). While only found to be significantly correlated twice, this determinant played a role in the
majority of the study population in seven papers. Because ICP often mention vaccination not being
proposed as a reason for non-uptake, this determinant is related to the information factors, knowledge,
and HCW recommendation.
Attitude, covering the attitude to vaccinations in general, was mentioned in 14 studies and was
found to be positively correlated twice in multivariate analysis. The effect of a favourable attitude to
vaccinations in general was larger on uptake of influenza (adjusted odds ratio (aOR) 3.4 (95% confidence
interval (CI) 1.2–9.5)) than on uptake of pneumococcal vaccination (aOR 1.7 [95% CI 0.8–3.5]) [44].
Perceived risk of infection was mentioned equally often as attitude (n = 14) and was also positively
associated with uptake, in two of the four studies that tested for significance [46,59].
Although knowledge was only addressed in four papers, in two out of the three articles that tested
for significance a positive correlation was found. Recommendation of an HCW was studied in 12 out
of the 29 papers and a significant correlation was found in all eight papers that performed statistical
analysis. In addition, a frequently reported reason for not being vaccinated was that vaccination was
not offered or recommended, which we included under awareness.
Self-efficacy was reported in two papers. One reported that more than 10% of unvaccinated ICP
were unsure of how to arrange to receive the vaccines [56], while another reported that patients who
find it easier to attend a GP for vaccination, have a higher intention to get vaccinated (p < 0.001) [46].
Regarding intention to behaviour, one high-quality study expressed that 80% of their IBD study
population expressed to be willing to receive all of the recommended vaccinations, while only 9% had
ever received a pneumococcal vaccination and only 28% was vaccinated against influenza at the time of
participation in the study [58]. In another study with 17% influenza and 4% pneumococcal vaccination
uptake, the intention to be vaccinated next year was also high and not significantly different between
the vaccinated (89%) and unvaccinated group (80%) [59].
3.2.4. Barriers and Facilitators
Cost was only mentioned as a barrier in one paper that found a significant negative correlation
with uptake [36]. Lack of time (n = 2) and the inconvenience of another appointment (n = 4) were more
often given as reasons for declining vaccination.
3.3. Vaccination Uptake among Healthcare Workers
In HCW, influenza vaccination uptake is most widely studied. In 35 articles out of the 44, seasonal
influenza vaccination was the only vaccine studied, with uptake varying between 9% [63] to 97%
(mandatory policy) [96]. Most studies were conducted in Italy (n = 8), followed by France (n = 5) and
the USA (n = 5). All but one were designed as cross-sectional surveys, with sample sizes ranging from
77 [76] to 32,808 [91]. Seven studies mentioned the use of a theoretical model for their study, which
includes the HBM [88], the TPB [89], the risk perception attitude framework [93], the Triandis model
of interpersonal behaviour [81], the cognitive model of empowerment [99] or mixtures of different
models [64,79] (Table 1).
3.3.1. Predisposing Factors
Thirty-six articles studied at least one predisposing factor in relation to vaccination uptake (Table 4).
Of the 30 articles that studied age, 22 found that older healthcare workers had a significantly higher
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uptake. On the other hand, in the case of hepatitis B [84,95] and measles [78,82], younger HCW’s
had higher compliance. In the 27 papers that studied gender, being male was associated with higher
vaccination uptake in 13 studies. Five papers mentioned a significantly higher uptake in women,
one for rubella only [97], and another for hepatitis B only [82]. Occupation was studied in relation to
vaccination uptake in 18 articles. Sixteen papers showed that physicians had a significantly higher
uptake than other HCW. This also complies with the significant positive association between education
level and uptake that was found in five papers. Presence of a chronic disease resulted in significantly
higher uptake in seven studies. In three other studies investigating this factor, no association was
found. Having children at home was studied in nine papers, but six found no significant role for
this factor in vaccination uptake. Good vaccine compliance in the past turned out to be an excellent
predictor of uptake in all 11 studies investigating this factor.
3.3.2. Information Factors
The role of information sources in vaccination uptake was studied in six articles. When information
was gathered from evidence-based sources, uptake was significantly higher in all five studies that
investigated this source. On the other hand, uptake was lower when information was retrieved
from social media, television, or radio [63,92]. Only one study found that gaining information from
colleagues was associated with a higher uptake [78].
3.3.3. Cognitive Determinants
Perceived risk was the most frequently described determinant in HCWs. More specifically,
perceived personal risk of infection reflects the perceived risk to contract the VPD, including the
perceived susceptibility to get infected and the perceived severity of the disease if contracted. In 33
out of 35 papers mentioning perceived risk of infection, a significant positive relation was found
between this determinant and vaccination uptake (n = 13), or these reasons were mentioned in a
considerable part of the study group (n = 20). Furthermore, in 18 papers a high perceived risk to infect
patients was given as a reason for vaccination uptake. Perceived risk (vs. benefit) of vaccination was
mentioned in 34 papers. Fifteen studies reported a significant negative relation between perceived risk
and uptake, indicating that high perceived risk or low perceived benefit of the vaccination resulted
in lower uptake. Additionally, five papers mentioned that this determinant played a role in the
majority of the study population. Adequate knowledge of recommendations, effectiveness, and
side-effects of vaccinations was significantly positively associated with uptake in 11 papers; in four
studies, no significant association was found. Attitude towards vaccination was studied in 22 articles.
In half of them, a significant positive association with vaccination uptake was found. Social influence
(encouragement of colleagues, managers, family) was analysed in almost half of the studies (n = 15).
In only one study no association was found [66], but the others showed either a significant (n = 8)
or considerable (n = 6) positive relation with vaccination uptake. Specific for HCW are the social
arguments ‘I got vaccinated because it’s my duty as an HCW’ or ‘as an HCW, I have a role in the
prevention of epidemics/spread of diseases’, that we collected under the term ‘professional norms’.
This determinant was positively associated with uptake in all 15 studies focusing on this factor; in seven
out of 11 studies that tested for significance, this factor remained a strong predictor for uptake in
multivariate analysis.
3.3.4. Barriers and Facilitators
In comparison with the previous determinants, barriers and facilitators are relatively less studied.
Of the barriers, time-related factors were mentioned most frequently and played a considerable role
(>10%) in hindering uptake in seven studies. Costs turned out to be no barrier. The fact that the
vaccines were free of charge even appeared to be a reason for uptake in two studies [62,67]. On the
other hand, facilitators stimulating uptake were getting a reminder (n = 3), convenient time/place of
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distribution (n = 4), and getting a reward (n = 3). However, in none of the studies were the potential
rewards specified.
4. Discussion and Conclusions
Our review of the currently available literature shows that there are clear differences in determinants
that play a role in vaccination uptake in travellers, ICP, and HCW. For travellers, low perceived risk of
infection and low awareness of vaccination recommendations are most accountable for low uptake.
For ICP, awareness of the indication of vaccination plays an important role, together with receiving
vaccination recommendations from their treating physician. ICP have a high perceived risk of
vaccination, due to not only fear for general side-effects but also concerns about potential consequences
for their illness. For HCW, perceived risk of (the severity of) infection for themselves and for their
patients together with perceived benefits of vaccination contribute most to their vaccination behaviour.
Regarding predisposing factors, there is a clear positive relationship between age and influenza
vaccination uptake in all risk groups. This could be explained by the additional indication older people
have for influenza vaccination. However, for other vaccinations, this relationship is either inverted or
non-existent. Higher vaccination uptake was seen in males in HCW and ICP, which could be associated
with the fact that females worry more about vaccine safety and efficacy than males [107]. Indeed,
more side-effects are reported by females, while on the other hand, from a biological perspective,
females typically mount higher antibody responses [107]. Although we did not find a clear relationship
between education level and vaccination uptake in the risk groups, in HCW the uptake was markedly
higher in physicians compared to other HCW. Overall, vaccination history seems to be an excellent
universal predictor of future vaccination uptake, probably due to unaltered cognitive determinants.
Regarding cognitive determinants, the greatest diversity between risk groups was found in
awareness. In ICP, almost two-thirds of the studies mentioned limited awareness, compared to
one-third in travellers and none in HCW. With their education and occupation, it seems quite obvious
that HCW are aware of the opportunities and indications for vaccinations. The fact that ICP seem
less aware than travellers might have to do with travellers taking an active decision to go abroad
realizing that they have to prepare themselves, while patients get passively diagnosed with a disease,
and are more dependant of the HCW for information provision. In all groups, HCW as a source of
information has a positive effect on uptake. The strong relationship between HCW recommendations
and vaccination uptake in ICP (reaching odds ratios up to 53 [52] and 187 [44]), underline the importance
of positive attitudes towards vaccination in HCW themselves [100,108].
In general, knowledge has a positive influence on uptake in all risk groups. However, since several
studies showed no relation between knowledge and uptake [19,35,62,66,71,95], improving education
alone will probably not be sufficient to increase uptake. In all groups, the perceived susceptibility
and severity of diseases on one hand and the perceived effectiveness and risks of vaccinations on
the other hand are important determinants predicting uptake. Especially ICP and HCW express
concerns about the safety and effectiveness of vaccines particularly for influenza vaccination [38,44].
And although the effectiveness of influenza vaccination varies with the coverage of circulating strains
each year, another part of the perceived lack of effectiveness could also be explained by the lack of
protection for other common cold viruses that can cause influenza-like symptoms [109]. Travelers
seem to have low risk perceptions for the diseases they could be vaccinated for as well as for the
potential negative effects of vaccination. Despite the high morbidity and mortality of some VPD
such as yellow fever, hepatitis B, and influenza, in all risk groups, some participants stated they
preferred natural immunization or were against vaccinations in general. Remarkably, attitudes differ for
specific vaccinations, for instance, people tend to have a more positive attitude towards pneumococcal
vaccination in comparison to the seasonal influenza vaccination [55]. Interestingly, the mistrust of ICP
and HCW towards the vaccinations produced by the pharmaceutical industry seems disproportionate
to therapeutics manufactured by the same pharmaceutical companies [40,50,72,78]. Here, the difference
between prevention and treatment might play a role, where the latter provides a more direct and visible
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effect. Another possible reason for the negative general attitude towards vaccination, also described in
decision making for childhood vaccinations [110], is the increasing tendency for self-empowerment
towards personal health decisions. In this view, individuals stand up against imposed policies and
want to make their own decisions, which could also be judged by peers as independent and smart
decision making [110,111]. At the same time, sources that are being used to make personal health
decisions, such as the internet, contain a lot of negative stories [112].
Practical barriers and facilitators play a limited role in vaccination uptake compared to the other
determinants. In all three groups, a reminder is an important facilitator and (lack of) time an important
barrier. Especially for HCW, this factor is interesting. Physicians report this factor most frequently [73].
They do not only experience lack of time to get vaccinated, they also feel that lack of time impedes their
duty to recommend vaccinations to their patients [113]. Again, as HCW recommendations are strongly
positively associated with uptake, not only in the other risk groups, but also for HCW themselves
(by colleagues for example) [66,80], removing this barrier can result in achieving optimal care for
all groups.
Only 16 of the 90 articles that were analysed in this review were based on a health behaviour
model. Many of those found determinants which contributed to vaccination uptake to a greater or
lesser extent [46,64,79,93,99]. Interventions that focus on a single determinant, such as knowledge,
repeatedly proved to be ineffective in the past [66], while multifactorial cognitive intervention strategies
are effective to improve uptake [114,115]. Therefore, all determinants that play a role have to be taken
into account. Predisposing factors could be used to target specific subgroups and personalize uptake
strategies [93]. Facilitators and barriers could be added or taken away to increase vaccination uptake.
But, most importantly, interventions need to address cognitive determinants. Interventions that
increase awareness and risk perception of infectious diseases are more effective than those decreasing
risk perceptions of vaccination by providing scientific information [116]. Social norms can be influenced
in the case of hierarchical relationships, for instance, the employer will have an effect on the vaccination
decision of HCW and HCW will impact ICP’s decisions. Therefore, multifactorial interventions are
needed that address the most important cognitive determinants. As these include awareness and risk
perceptions, reminders and incidence data could help. Reminders for travellers could be disseminated
in general media before holidays, while for ICP patient associations and HCW could play a role.
To improve risk perceptions for the infections, cases of vaccine-preventable diseases should be made
public. To decrease risk perceptions of negative effects of vaccinations (e.g., adverse events) new
studies should compare the number of influenza-like illnesses in vaccinated and non-vaccinated
groups. Furthermore, social norms can be included by making the decisions of vaccination uptake
public. For example, in HCW trials have been implemented to test the effects of providing a pin that
vaccinated HCW may wear that is saying “deliberately vaccinated”, which could affect both colleagues
and patients [117].
Vaccination decisions of travellers and ICP are less well studied than those of HCW. Additionally,
data on uptake of vaccinations other than influenza are limited. As the available data show large
differences in determinants predicting uptake of influenza versus other vaccinations, further studies
are required regarding the uptake of recommended vaccinations for diseases other than influenza.
Reaching a more comprehensive understanding of vaccination uptake in different risk groups for the
different vaccinations that are indicated, interventions can be developed based on evidence. Moreover,
this understanding could help with the implementation of new vaccines for certain risk groups, for
instance when a novel SARS-CoV-2 vaccine will be recommended for HCW.
A number of limitations have to be taken into account when interpreting the results of this review.
First, articles were only included if they discussed any cognitive determinants that were possibly related
to vaccination uptake. This resulted in the exclusion of papers that looked only, although thoroughly,
into predisposing factors. Secondly, there was a high level of heterogeneity in the determinants
reported, as studies used various health behaviour models as a framework for their studies, and
many did not even use a model but just reported results of questionnaires with either open-ended
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or multiple-choice questions. Furthermore, the influence of determinants on vaccination uptake was
measured with different statistical analyses, which also contributed to the high heterogeneity of the
data. Therefore, we choose to report the significance and direction of the association, instead of the
magnitude. In addition, we choose to compare three different risk groups that we think are important,
thereby we could not discuss all determinants in depth. Finally, included studies were based on
self-reported vaccination behaviour. Therefore, we have to take into account a certain level of social
desirability and recall bias.
To our knowledge, this is the first review that provides a comprehensive overview of health
behavioural determinants explaining vaccination uptake in three different risk groups, namely travellers,
ICP, and HCW. We showed that there is a large diversity of determinants that affect uptake to a greater
or lesser extent. Therefore, we argue that future studies and interventions should be based on
multifactorial health behaviour models, especially for travellers and ICP as only a limited number of
such studies is available yet.
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